Simpler Grants.gov #RFA-AI-27-005

NIH Clinical Research Network on Antimicrobial Resistance Funding Opportunity

This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), seeks to establish a Clinical Research Network focused on Antimicrobial Resistance (AMR): - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Purpose and Scope: - Establish a Clinical Research Network to address key clinical questions related to bacterial and fungal AMR - Activities include clinical testing of new antibiotics and treatments (e.g., bacteriophage therapy), optimizing use of existing antibiotics, evaluating novel diagnostic tests, and mentoring new AMR clinical researchers - Funding and Award Details: - Cooperative agreement with a total value of $15,000,000 - Only one recipient is expected to be awarded - Products/Services Requested: - No specific OEMs, vendors, or commercial products are named; this is a research network solicitation - Main service is the design, implementation, and management of clinical research and mentoring activities in AMR - Unique Requirements: - Emphasis on mentoring new clinical researchers in AMR - Focus on both bacterial and fungal infections - Includes evaluation of novel diagnostic tests and innovative therapies - Place of Performance: - National Institutes of Health (NIH)

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to support a Clinical Research Network on Antimicrobial Resistance (AMR), focusing on bacterial and fungal infections associated with AMR. The program aims to design, implement, and manage clinical research addressing key clinical questions in AMR, including clinical testing of new antibiotics and treatments, optimizing the use of existing antibiotics, evaluating novel diagnostic tests, and mentoring new AMR clinical researchers. The funding opportunity is a cooperative agreement with a total funding of $15,000,000 and expects to award one recipient. The estimated application due date is September 29, 2026, with an estimated award date of July 1, 2027.

View original listing